Clinical outcomes after treatment of multiple lesions with zotarolimus-eluting versus sirolimus-eluting coronary stents (a SORT OUT III substudy)

被引：0
|
作者：
Troels Thim
Michael Maeng
Jens Flensted Lassen
Anne Kaltoft
Lisette Okkels Jensen
Jan Ravkilde
Per Thayssen
Søren Galatius
Evald Høj Christiansen
Thomas Engstrøm
Morten Madsen
Leif Thuesen
Hans Henrik Tilsted
机构：
[1] Aarhus University Hospital,Department of Cardiology
[2] Odense University Hospital,Department of Cardiology
[3] Aarhus University Hospital Aalborg,Department of Cardiology
[4] Gentofte University Hospital,Department of Cardiology
[5] Copenhagen University Hospital,Department of Cardiology, Rigshospitalet
[6] Aarhus University Hospital,Department of Clinical Epidemiology
[7] Aarhus University Hospital,Department of Cardiology
来源：
BMC Cardiovascular Disorders | / 12卷
关键词：
Percutaneous Coronary Intervention; Major Adverse Cardiac Event; Drug Elute Stent; Multiple Lesion; Target Lesion Revascularization;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
下载
收藏
相关论文
共 50 条
  • [1] Clinical outcomes after treatment of multiple lesions with zotarolimus-eluting versus sirolimus-eluting coronary stents (a SORT OUT III substudy)
    Thim, Troels
    Maeng, Michael
    Lassen, Jens Flensted
    Kaltoft, Anne
    Jensen, Lisette Okkels
    Ravkilde, Jan
    Thayssen, Per
    Galatius, Soren
    Christiansen, Evald Hoj
    Engstrom, Thomas
    Madsen, Morten
    Thuesen, Leif
    Tilsted, Hans Henrik
    BMC CARDIOVASCULAR DISORDERS, 2012, 12
  • [2] Clinical outcome after implantation of zotarolimus-eluting versus sirolimus-eluting stents in patients with single or multiple lesions. An 18 month SORT OUT III substudy
    Tilsted, H. -H.
    Maeng, M.
    Jensen, L. O.
    Kaltoft, A.
    Thayssen, P.
    Ravkilde, J.
    Madsen, M.
    Soerensen, H. T.
    Thuesen, L.
    Lassen, J. F.
    EUROPEAN HEART JOURNAL, 2010, 31 : 153 - 154
  • [3] Zotarolimus-eluting vs. sirolimus-eluting coronary stents in patients with and without acute coronary syndromes: a SORT OUT III substudy
    Thim, Troels
    Maeng, Michael
    Kaltoft, Anne
    Jensen, Lisette O.
    Tilsted, Hans H.
    Hansen, Peter R.
    Kelbaek, Henning
    Thayssen, Per
    Ravkilde, Jan
    Madsen, Morten
    Sorensen, Henrik T.
    Thuesen, Leif
    Lassen, Jens F.
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2012, 42 (10) : 1047 - 1054
  • [4] Clinical outcome after coronary implantation of zotarolimus-eluting versus sirolimus-eluting stents in patients with diabetes mellitus: an 18-month Sort Out III substudy
    Maeng, M.
    Jensen, L. O.
    Tilsted, H.
    Kaltoft, A.
    Thayssen, P.
    Ravkilde, J.
    Madsen, M.
    Soerensen, H. T.
    Thuesen, L.
    Lassen, J. F.
    EUROPEAN HEART JOURNAL, 2010, 31 : 926 - 926
  • [5] Ten-Year Outcomes of Sirolimus-Eluting Versus Zotarolimus-Eluting Coronary Stents in Patients With Versus Without Diabetes Mellitus (SORT OUT III)
    Olesen, Kevin K. W.
    Pareek, Manan
    Madsen, Morten
    Jensen, Lisette O.
    Christiansen, Evald H.
    Thuesen, Leif
    Lassen, Jens F.
    Kristensen, Steen Dalby
    Botker, Hans Erik
    Maeng, Michael
    AMERICAN JOURNAL OF CARDIOLOGY, 2020, 125 (03): : 349 - 353
  • [6] Outcome of Sirolimus-Eluting Versus Zotarolimus-Eluting Coronary Stent Implantation in Patients With and Without Diabetes Mellitus (a SORT OUT III Substudy)
    Maeng, Michael
    Jensen, Lisette O.
    Tilsted, Hans-Henrik
    Kaltoft, Anne
    Kelbaek, Henning
    Abildgaard, Ulrik
    Villadsen, Anton
    Aaroe, Jens
    Thayssen, Per
    Krusell, Lars R.
    Christiansen, Evald H.
    Botker, Hans E.
    Kristensen, Steen D.
    Ravkilde, Jan
    Madsen, Morten
    Sorensen, Henrik T.
    Rasmussen, Klaus
    Thuesen, Leif
    Lassen, Jens F.
    AMERICAN JOURNAL OF CARDIOLOGY, 2011, 108 (09): : 1232 - 1237
  • [7] Ten-year outcomes from a randomised comparison of zotarolimus-eluting and sirolimus-eluting stents: the SORT OUT III study
    Pareek, Manan
    Madsen, Morten
    Olesen, Kevin K. Warnakula
    Jensen, Lisette Okkels
    Christiansen, Evald Hoj
    Kristensen, Steen Dalby
    Lassen, Jens Flensted
    Thuesen, Leif
    Botker, Hans Erik
    Maeng, Michael
    EUROINTERVENTION, 2019, 15 (11) : E1022 - E1024
  • [8] 10-year outcomes from a randomized comparison of zotarolimus-eluting and sirolimus-eluting stents: the SORT OUT III study
    Pareek, M.
    Jensen, L. O.
    Christiansen, E. H.
    Aaroe, J.
    Jensen, J. S.
    Kristensen, S. D.
    Lassen, J. F.
    Thuesen, L.
    Madsen, M.
    Boetker, H. E.
    Maeng, M.
    EUROPEAN HEART JOURNAL, 2018, 39 : 272 - 272
  • [9] Efficacy and safety of zotarolimus-eluting and sirolimus-eluting coronary stents in routine clinical care (SORT OUT III): a randomised controlled superiority trial
    Rasmussen, Klaus
    Maeng, Michael
    Kaltoft, Anne
    Thayssen, Per
    Kelbaek, Henning
    Tilsted, Hans Henrik
    Abildgaard, Ulrik
    Christiansen, Evald Hoj
    Engstrom, Thomas
    Krusell, Lars Romer
    Ravkilde, Jan
    Hansen, Peter Riis
    Hansen, Knud Norregaard
    Abildstrom, Steen Zabell
    Aaroe, Jens
    Jensen, Jan Skov
    Kristensen, Steen Dalby
    Botker, Hans Erik
    Madsen, Morten
    Johnsen, Soren Paaske
    Jensen, Lisette Okkels
    Sorensen, Henrik Toft
    Thuesen, Leif
    Lassen, Jens Flensted
    LANCET, 2010, 375 (9720): : 1090 - 1099
  • [10] Clinical Outcome In Patients With Single Or Multiple Lesions After Implantation Of Zotarolimus Or Sirolimus-Eluting Stents- an 18-Month SORT OUT III Substudy
    Tilsted, Hans-Henrik
    Maeng, Michael
    Jensen, Lisette Okkels
    Kaltofi, Anne
    Thayssen, Per
    Ravkilde, Jan
    Madsen, Morten
    Soerensen, Henrik Toft
    Thuesen, Leif
    Lassen, Jens Flensted
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 56 (13) : B9 - B9
12345